IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q4 2023 Holdings

Filed 2024-02-14 | 8 holdings | $109.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Icosavax IncCOM45114M109$55.3M3,510,22850.7%
Korro BIO Inc(KRRO)COM500946108$17.6M368,08516.2%
Tourmaline BIO Inc(TRML)COM89157D105$16.8M641,69115.4%
Hillevax IncCOM43157M102$9.0M558,9238.2%
Jasper Therapeutics IncCOM471871103$6.7M8,519,6486.2%
Ventyx Biosciences Inc(VTYX)COM92332V107$1.7M686,3701.6%
Elevation Oncology IncCOM28623U101$1.3M2,370,1421.2%
Kezar Life Sciences IncCOM49372L100$785.1K828,7110.7%